Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function

J Am Heart Assoc. 2020 Aug 18;9(16):e016537. doi: 10.1161/JAHA.120.016537. Epub 2020 Aug 5.

Abstract

Background We sought to determine (1) long-term outcomes in patients presenting with documented Takotsubo syndrome (TS), (2) whether left ventricular global longitudinal strain (LV-GLS) provides incremental prognostic value, and (3) prognostic cutoffs of LV ejection fraction (LVEF) and LV-GLS during an acute TS episode. Methods and Results We studied 650 patients with TS (aged 66±14 years, 88% women) who were diagnosed clinically and angiographically between 2006 and 2018. Baseline LVEF and LV-GLS (using velocity vector imaging) were recorded. The primary end point was all-cause mortality. TS triggers were unknown (34%), emotional (16%), physical (41%), and neurologic (10%). Mean LVEF and LV-GLS were 36±10% and -11.6±0.4%; in addition, 94% patients had LVEF <52%, and 80% had apical ballooning. No patient had obstructive coronary artery disease. At a median of 2.2 years (interquartile range, 0.7-4.4), 175 (27%) had died (9% in-hospital deaths). Multivariate Cox survival analysis revealed that higher age (hazard ratio [HR], 1.35), male sex (HR, 1.75), lower baseline LVEF (HR, 1.02), worse LV-GLS (HR, 1.04), neurologic trigger (HR, 2.66), and physical trigger (HR, 2.64) were associated with mortality, whereas aspirin (HR, 0.70) and β-blockers (HR, 0.73) improved survival (all P<0.049). The addition of LVEF and LV-GLS to clinical markers (age, sex, cardiogenic shock at presentation, and peak troponin I) significantly increased log-likelihood ratios: clinical (-521.48), clinical plus LVEF (-511.32, P<0.001), and clinical plus LVEF and LV-GLS (-500.68, P<0.001). On penalized spline analysis, LVEF of 38% and LV-GLS of -10% were cutoffs below which survival was significantly worse. Conclusions Patients with TS with a neurologic or physical trigger had significantly worse survival than those without such a trigger, with baseline LVEF and LV-GLS providing incremental prognostic value.

Keywords: Takotsubo; outcomes; strain.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Age Factors
  • Aged
  • Aspirin / administration & dosage
  • Echocardiography
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Hospital Mortality
  • Humans
  • Male
  • Prognosis
  • Sex Factors
  • Systole / physiology
  • Takotsubo Cardiomyopathy / drug therapy
  • Takotsubo Cardiomyopathy / etiology
  • Takotsubo Cardiomyopathy / mortality
  • Takotsubo Cardiomyopathy / physiopathology*
  • Ventricular Function, Left / physiology*

Substances

  • Adrenergic beta-Antagonists
  • Fibrinolytic Agents
  • Aspirin